Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 55 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
541 17.0 months Epithelial ovarian cancer or primary peritoneal cancer 4 Biologic therapy
Irvine Medical Center United States 11/2007
Treatment Details: Patients: This phase II study involved 62 women with persistent or recurrent epithelial ovarian or peritoneal cancer. The median age was 57 years, ranging from 18 to 79. Most (66.1%) had
 
542 17.0 months Advanced, hormone sensitive breast cancer 3 Biologic therapy
Oncologisch Centrum Sint-Augustinus Belgium 3/2008
Treatment Details: Patients: This phase II study involved 111 women with advanced, hormone-sensitive breast cancer. The median age was 56 years, ranging from 28 to 82. Treatment: Patients were treated w
 
543 17.0 months Castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Roswell Park Cancer Institute United States 5/2010
Treatment Details: Patients: This study involved patients with castration-refractory prostate cancer. Patients were divided into 2 separate treatment groups. Group A included 33 men with a median age of 68
 
544 17.0 months Metastatic breast cancer 3 Chemotherapy
‘‘A. Perrino’’ Hospital Italy 7/2011
Treatment Details: Patients: This study involved 60 women with previously treated metastatic breast cancer. The median age was 63 years. Treatment: Patients were treated with the chemotherapy agent capec
 
545 17.0 months Newly diagnosed GBM multiforme, New diagnosed gliosarcoma 4 Biologic therapy
Chemotherapy
Radiation
University of California, San Francisco United States 9/2011
Treatment Details: Patients: This phase II study involved 66 patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma. The median patient age was 57 years. The breakdown of patient gender
 
546 17.0 months Metastatic breast cancer 4 Chemotherapy
Columbia University/New York Presbyterian Hospital United States 2/2003
Treatment Details: Patients: This Phase II trial involved 31 (assessable) patients with metastatic breast cancer. Patients had been treated previously with hormonal therapy and/or chemotherapy and/or radiatio
 
547 17.0 months Stage IIIA, N2 NSCLC 3 Chemotherapy
Surgery
National Cancer Center Hospital East Japan 2/2003
Treatment Details: Patients: This study involved a total of 62 patients with stage IIIA, N2 non-small-cell lung cancer. Patients were divided into two groups (A and B) of 31 patients each. Treatment: Gr
 
548 17.0 months Advanced NSCLC 5 Chemotherapy
Radiation
Asian Medical Center Korea 5/2005
Treatment Details: Patients: This Phase II study involved 135 patients with locally advanced NSCLC (stage IIIB). 122 of the patients were men, and 13 were women. The median age was 60 years. None of the pat
 
549 17.0 months Recurrent ovarian cancer 4 Chemotherapy
CHA Gangnam Medical Center, CHA University Korea 9/2013
Treatment Details: Patients: This phase 2 study involved 47 recurrent ovarian cancer patients with a median age of 50 years. Treatment: Patients were treated with the chemotherapy agents ifosfamide and ci
 
550 17.0 months Metastatic melanoma 5 Biologic therapy
Immunotherapy
The Ohio State University United States 7/2011
Treatment Details: Patients: This phase 2 study involved 25 metastatic melanoma patients. The median patient age was 56 years and 16 were male. Treatment: Patients were treated with the biologic therapy
 
Page 55 of 187  | Previous Page  | Next Page